{
  "paper_id": "4090d8537051fae501355bc567dc2dec620762eb",
  "metadata": {
    "title": "Journal Pre-proof Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis Prevalence of comorbidities in the Novel Wuhan Coronavirus (COVID-19) infection: a systematic review and meta-analysis",
    "coda_data_split": "test",
    "coda_paper_id": 672,
    "coda_has_expert_labels": false,
    "subset": "custom_license"
  },
  "abstract": [
    {
      "original_text": " COVID -19 cases now confirmed in multiple countries.",
      "sentences": [
        [
          {
            "segment_text": "COVID -19 cases now confirmed in multiple countries .",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": " assessed the prevalence of comorbidities in infected patients.  comorbidities are risk factors for severe patients compare with Non-severe.",
      "sentences": [
        [
          {
            "segment_text": "assessed the prevalence of comorbidities in infected patients .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "comorbidities are risk factors for severe patients compare with Non-severe .",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": "J o u r n a l P r e -p r o o f 2  help the health sector guide vulnerable populations and assess the risk of deterioration.",
      "sentences": [
        [
          {
            "segment_text": "J o u r n a l P r e - p r o o f 2 help the health sector guide vulnerable populations and assess the risk of deterioration .",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": "Background: An outbreak of Novel Coronavirus in Wuhan, China, the epidemic is more widespread than initially estimated, with cases now confirmed in multiple countries.",
      "sentences": [
        [
          {
            "segment_text": "Background : An outbreak of Novel Coronavirus in Wuhan ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "China , the epidemic is more widespread than initially estimated ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "with cases now confirmed in multiple countries .",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": "The aim of the meta-analysis was to assess the prevalence of comorbidities in the COVID-19 infection patients and the risk of underlying diseases in severe patients compared to non-severe patients.",
      "sentences": [
        [
          {
            "segment_text": "The aim of the meta-analysis was to assess the prevalence of comorbidities in the COVID-19 infection patients and the risk of underlying diseases in severe patients compared to non-severe patients .",
            "crowd_label": "purpose"
          }
        ]
      ]
    },
    {
      "original_text": "A literature search was conducted using the databases PubMed, EMBASE, and Web of sciences until February 25, 2020. Risk ratio (OR) and 95% confidence intervals (CIs) were pooled using random-effects models.",
      "sentences": [
        [
          {
            "segment_text": "A literature search was conducted using the databases PubMed ,",
            "crowd_label": "method"
          },
          {
            "segment_text": "EMBASE , and Web of sciences until February 25 , 2020 .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "Risk ratio ( OR ) and 95 % confidence intervals ( CIs ) were pooled using random-effects models .",
            "crowd_label": "method"
          }
        ]
      ]
    },
    {
      "original_text": "Results: Eight studies were included in the meta-analysis, including 46248 infected patients. The result showed the most prevalent clinical symptom was fever ( 91±3, 95% CI 86-97% ), followed by cough (67±7, 95% CI 59-76%), fatigue ( 51±0, 95% CI 34-68% ) and dyspnea ( 30±4, 95% CI 21-40%). The most prevalent comorbidity were hypertension (17±7, 95% CI 14-22%) and diabetes ( 8±6, 95% CI 6-11% ), followed by cardiovascular diseases ( 5±4, 95% CI 4-7% ) and respiratory system disease( 2±0, 95% CI 1-3% ). Compared with the Non-severe patient, the pooled odds ratio of hypertension, respiratory system disease, cardiovascular disease in severe patients were (OR 2.36, 95% CI: 1.46-3.83) ,(OR 2.46, 95% CI: 1.76-3.44) and (OR 3.42, 95% CI: 1.88-6.22)respectively.",
      "sentences": [
        [
          {
            "segment_text": "Results : Eight studies were included in the meta-analysis , including 46248 infected patients .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "The result showed the most prevalent clinical symptom was fever ( 91 ± 3 , 95 % CI 86-97 % ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "followed by cough ( 67 ± 7 , 95 % CI 59-76 % ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "fatigue ( 51 ± 0 , 95 % CI 34-68 % ) and dyspnea ( 30 ± 4 , 95 % CI 21-40 % ) .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "The most prevalent comorbidity were hypertension ( 17 ± 7 , 95 % CI 14-22 % ) and diabetes ( 8 ± 6 , 95 % CI 6-11 % ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "followed by cardiovascular diseases ( 5 ± 4 , 95 % CI 4-7 % ) and respiratory system disease ( 2 ± 0 , 95 % CI 1-3 % ) .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Compared with the Non-severe patient ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "the pooled odds ratio of hypertension ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "respiratory system disease , cardiovascular disease in severe patients were ( OR 2.36 , 95 % CI : 1.46-3.83 ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "( OR 2.46 , 95 % CI : 1.76-3.44 ) and ( OR 3.42 , 95 % CI : 1.88-6.22 ) respectively .",
            "crowd_label": "finding"
          }
        ]
      ]
    },
    {
      "original_text": "We assessed the prevalence of comorbidities in the COVID-19 infection patients and found underlying disease, including hypertension, respiratory system disease and cardiovascular, may be a risk factor for severe patients compared with Non-severe patients.",
      "sentences": [
        [
          {
            "segment_text": "We assessed the prevalence of comorbidities in the COVID-19 infection patients and found underlying disease ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "including hypertension , respiratory system disease and cardiovascular ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "may be a risk factor for severe patients compared with Non-severe patients .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "8",
    "sentence_num": "13",
    "segment_num": "24",
    "token_num": "396"
  }
}